NIH-funded research NIH-funded research

Developing new tests to find better pain relief options

Official title: Assay Development, Screening and Early Optimization

Funded at Univ of North Carolina Chapel Hill · NIH-10974397 · Data updated 2026-11-12

This study is working on new lab tests to find better ways to treat pain by looking at how different compounds affect pain receptors in the brain, using mice to help understand their effects, and using computer methods to improve these treatments for people with pain disorders.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 19, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$1,576,534
NIH project number1U19NS138975-01
Project IDNIH-10974397 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from chronic pain conditions who are seeking new treatment options.

Less likely to help

Patients who do not experience pain or have conditions unrelated to pain management may not benefit from this research.

What this research studies

This research focuses on creating new laboratory tests to identify and evaluate potential treatments for pain disorders. The team will develop innovative assays that allow them to study how certain compounds interact with pain-related receptors in the brain. By using advanced techniques, including genetic modifications in mice, they will analyze the effects of these compounds on neuron activity, which could lead to more effective pain management strategies. The research also includes large-scale computational methods to optimize these potential treatments.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective pain relief medications with fewer side effects.

How similar studies have gone: Previous research has shown promise in developing similar assays and computational approaches for pain management, indicating potential for success in this area.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Scherrer, Gregory — Univ of North Carolina Chapel Hill
  • Study coordinator: Scherrer, Gregory

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.